Corporate Natco Pharma Limited March 3, 2026 Natco Pharma Limited has informed the Exchange regarding a press release dated March 03, 2026, titled “NATCO announces launch of Pomalidomide Capsules (generic of Pomalyst®) in the U.S. market”. |SUBJECT: Press Release Post navigation Food Corporation of India Ruchira Papers Limited Related Posts Canara Bank Canara Bank has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper… May 16, 2026 Dabur India Limited Dabur India Limited has informed the Exchange about imposition of Penalty |SUBJECT: Action(s) taken or… April 10, 2026 Sansera Engineering Limited Sansera Engineering Limited has informed the Exchange regarding Grant of 25000 Options. |SUBJECT: ESOP/ESOS/ESPS March 29, 2026 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Canara Bank Canara Bank has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper… May 16, 2026
Dabur India Limited Dabur India Limited has informed the Exchange about imposition of Penalty |SUBJECT: Action(s) taken or… April 10, 2026
Sansera Engineering Limited Sansera Engineering Limited has informed the Exchange regarding Grant of 25000 Options. |SUBJECT: ESOP/ESOS/ESPS March 29, 2026